Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2

Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States

(2018) Anne M. Butler et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study

(2018) Jiafeng Shou et al.   PROSTATE

Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer

(2016) Sameerah Shaheen et al.   Stem Cell Reviews and Reports

Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer

(2016) Sameerah Shaheen et al.   Stem Cell Reviews and Reports

Epithelial-Mesenchymal Transition and Breast Cancer

(2016) Yanyuan Wu et al.   Journal of Clinical Medicine

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis

(2016) Collene R Jeter et al.   Cell Discovery

Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis

(2015) Mohammad Khan et al.   CURRENT PHARMACEUTICAL DESIGN

Regulation of tumor cell plasticity by the androgen receptor in prostate cancer

(2015) J. L. Bishop et al.   ENDOCRINE-RELATED CANCER

Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer

(2015) Yunhee Cho et al.   Oncotarget

Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells

(2015) Theerawut Chanmee et al.   Frontiers in Oncology

Expression of Androgen and Estrogen Signaling Components and Stem Cell Markers to Predict Cancer Progression and Cancer-Specific Survival in Patients with Metastatic Prostate Cancer

(2014) T. Fujimura et al.   CLINICAL CANCER RESEARCH

The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells

(2014) Steven Kregel et al.   PROSTATE

SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/β-catenin signal network

(2013) Xuefei Li et al.   CANCER LETTERS

Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer

(2013) Steven Kregel et al.   PLoS One

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer

(2013) Chun-Liang Chen et al.   PROSTATE

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

(2013) M. Yu et al.   SCIENCE

SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

(2013) M Herreros-Villanueva et al.   Oncogenesis

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis

(2012) Aditi Gupta et al.   Molecular Cancer

Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients

(2012) Xu Han et al.   PLoS One

Elevating SOX2 Levels Deleteriously Affects the Growth of Medulloblastoma and Glioblastoma Cells

(2012) Jesse L. Cox et al.   PLoS One

Prostate cancer epidemiology in the United States

(2012) Otis W. Brawley   WORLD JOURNAL OF UROLOGY

Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy

(2011) Y. Sun et al.   CANCER RESEARCH

Hyaluronan-CD44 interactions as potential targets for cancer therapy

(2011) Suniti Misra et al.   FEBS Journal

Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

(2011) A. J. Armstrong et al.   MOLECULAR CANCER RESEARCH

Sox2 expression in breast tumours and activation in breast cancer stem cells

(2011) O Leis et al.   ONCOGENE

The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer

(2011) Archana Dhasarathy et al.   PLoS One

SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell

(2011) X. Jia et al.   Journal of Molecular Cell Biology

Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells

(2010) Dejuan Kong et al.   PLoS One

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature

(2009) George J. Klarmann et al.   CLINICAL & EXPERIMENTAL METASTASIS

Castration-Resistant Prostate Cancer: Locking Up the Molecular Escape Routes

(2009) R. M. Attar et al.   CLINICAL CANCER RESEARCH

Epithelial–mesenchymal transition in development and cancer

(2009) Douglas S Micalizzi et al.   Future Oncology

Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

(2009) B. Desai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL